Laxacin
- Product NDC
- 50488-0901
- 11-digit product format
- 504880901
- Labeler code
- 50488
- Product ID
- 50488-0901_1b45f6d1-4436-4b3a-813b-7043c0d0fad6
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Docusate sodium and sennosides
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Alexso, Inc
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-10-15
- Substance
- DOCUSATE SODIUM; SENNOSIDES A AND B
- Active strength
- 50; 8.6 mg/1; mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Laxacin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOCUSATE SODIUM | 50 mg/1 |
| SENNOSIDES A AND B | 8.6 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | F05Q2T2JA0, 1B5FPI42EN |
| Rxcui | 998740, 2106884 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50488-0901-1 | Laxacin | 100 in 1 BOTTLE | TABLET | 100 | | 8 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| SENNOSIDES A AND B | ACTIVE INGREDIENT | 1B5FPI42EN | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| DOCUSATE | ACTIVE MOIETY | M7P27195AG | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| SENNOSIDES A AND B | ACTIVE MOIETY | 1B5FPI42EN | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| DEXTROSE | INACTIVE INGREDIENT | IY9XDZ35W2 | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| SENNOSIDES A AND B | ACTIVE INGREDIENT | 1B5FPI42EN | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| DOCUSATE | ACTIVE MOIETY | M7P27195AG | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| SENNOSIDES | ACTIVE MOIETY | 3FYP5M0IJX | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| DEXTROSE | INACTIVE INGREDIENT | IY9XDZ35W2 | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50488-0901 | LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO, INC] | 8 | Current NDC, Legacy NDC, 1 package rows | 20241208_0df9abaf-3997-4dde-8003-ae3d8d07cf39.zip |
DailyMed RxNorm Mappings#
RxCUI, RxNorm string, TTY table| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|
| 2106884 | Laxacin 50 MG / 8.6 MG Oral Tablet | PSN | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 998740 | sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet | PSN | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 2106884 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin] | SBD | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 998740 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SCD | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 998740 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SY | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 2106884 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin] | SY | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 2106884 | Laxacin 50 MG / 8.6 MG Oral Tablet | SY | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 8 |
| 2106884 | Laxacin 50 MG / 8.6 MG Oral Tablet | PSN | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 2106884 | Laxacin 50 MG / 8.6 MG Oral Tablet | PSN | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
| 998740 | sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet | PSN | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 998740 | sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet | PSN | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
| 2106884 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin] | SBD | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 2106884 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin] | SBD | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
| 998740 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SCD | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 998740 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SCD | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
| 998740 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SY | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 998740 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SY | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
| 2106884 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin] | SY | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 2106884 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin] | SY | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
| 2106884 | Laxacin 50 MG / 8.6 MG Oral Tablet | SY | 57fca238-ba1e-4b05-abda-a8333da8132a | 2 |
| 2106884 | Laxacin 50 MG / 8.6 MG Oral Tablet | SY | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50488-0901-1 | 50488090101 | 100 TABLET in 1 BOTTLE (50488-0901-1) | 100 tablet | 2018-10-15 | 0000-00-00 | No | No | Current |